Results from such IHC analysis confirmed that the JLP-silenced ovarian tumor xenografts exhibited reduced expression of JLP with the concomitant reduction in the expression levels of JNK as well as its phosphorylated activation profile (Figure 6A). Here, MAPK8 is linked to ovarian neoplasm.